Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Price:
41.975 USD
-2.97%
Market Closed
Updated:
May 29, 2024
Amphastar Pharmaceuticals Inc
Other Receivables
|
Amphastar Pharmaceuticals Inc
Other Receivables Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
Other Receivables
$784k
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-14%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Receivables
$4.8B
|
CAGR 3-Years
49%
|
CAGR 5-Years
38%
|
CAGR 10-Years
14%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Receivables
$4.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Receivables
$744m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Receivables
$2.1B
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
11%
|
See Also
What is Amphastar Pharmaceuticals Inc's Other Receivables?
Other Receivables
784k
USD
784k
USD
Based on the financial report for Mar 31, 2024, Amphastar Pharmaceuticals Inc's Other Receivables amounts to 784k USD.
What is Amphastar Pharmaceuticals Inc's Other Receivables growth rate?
Other Receivables CAGR 10Y
-14%
-14%
Over the last year, the Other Receivables growth was -2%. The average annual Other Receivables growth rates for Amphastar Pharmaceuticals Inc have been -1% over the past three years , -13% over the past five years , and -14% over the past ten years .
You don't have any saved screeners yet
